This concept is supported by studies demonstrating that Myc over-expression confers resistance to antiestrogens in vitro [17,18], and that inducible expression of c-Myc can replace estrogen in reinitiating cell cycle progression in antiestrogen-arrested breast cancer cells [12]. The gene discussed is MYC; the disease is breast cancer.